Terms: = Brain cancer AND ER, estrogen receptor AND Prognosis
142 results:
1. Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Roussot N; Constantin G; Desmoulins I; Bergeron A; Arnould L; Beltjens F; Mayeur D; Kaderbhai C; Hennequin A; Jankowski C; Padeano MM; Costaz H; Jacinto S; Michel E; Amet A; Coutant C; Costa B; Jouannaud C; Deblock M; Levy C; Ferrero JM; Kerbrat P; Brain E; Mouret-Reynier MA; Coudert B; Bertaut A; Ladoire S
Eur J Cancer; 2024 May; 202():114037. PubMed ID: 38554542
[TBL] [Abstract] [Full Text] [Related]
2. Protecting the brain: Novel Strategies for Preventing Breast cancer brain Metastases through Selective estrogen receptor β Agonists and In Vitro Blood-brain Barrier Models.
Kirchner J; Völker E; Shityakov S; Saji S; Förster CY
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542355
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
4. Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics.
Sokolov D; Sharda N; Banerjee A; Denisenko K; Basalious EB; Shukla H; Waddell J; Hamdy NM; Banerjee A
Curr Pharm Des; 2024; 30(1):31-47. PubMed ID: 38151840
[TBL] [Abstract] [Full Text] [Related]
5. A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules.
Iragavarapu-Charyulu V; Shakya R; Robinson P; Guzmán E; Tyulmenkova A; Pino JL; Isgor C
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131223
[TBL] [Abstract] [Full Text] [Related]
6. Cellular stress responses as modulators of drug cytotoxicity in pharmacotherapy of glioblastoma.
Kusaczuk M; Ambel ET; Naumowicz M; Velasco G
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189054. PubMed ID: 38103622
[TBL] [Abstract] [Full Text] [Related]
7. Dual targeting agent Thiotert inhibits the progression of glioblastoma by inducing ER stress-dependent autophagy.
Dong J; Qian Y; Zhang W; Wang Q; Jia M; Yue J; Fan Z; Jiang Y; Wang L; Wang Y; Huang Z; Yu L; Wang Y
Biomed Pharmacother; 2024 Jan; 170():115867. PubMed ID: 38101281
[TBL] [Abstract] [Full Text] [Related]
8. The Value of ER∝ in the prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations.
Dumitriu-Stan RI; Burcea IF; Nastase VN; Ceaușu RA; Dumitrascu A; Cocosila LC; Bastian A; Zurac S; Raica M; Poiana C
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003353
[TBL] [Abstract] [Full Text] [Related]
9. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning.
Zhong X; Lin Y; Zhang W; Bi Q
Sci Rep; 2023 Oct; 13(1):18301. PubMed ID: 37880320
[TBL] [Abstract] [Full Text] [Related]
10. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast cancer.
Pan WK; Ren SY; Zhu LX; Lin BC
Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
[TBL] [Abstract] [Full Text] [Related]
11. prognosis of breast cancer patients with brain metastasis treated with radiotherapy.
Simonsen MK; Vrou Offersen B; Jensen AB
Acta Oncol; 2023 Aug; 62(8):871-879. PubMed ID: 37498539
[TBL] [Abstract] [Full Text] [Related]
12. [WHO Histological Classification of Pituitary Tumors].
Nishioka H
No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
[TBL] [Abstract] [Full Text] [Related]
13. Breast cancer diagnosis and prognosis using a high b-value non-Gaussian continuous-time random-walk model.
Feng H; Liu H; Wang Q; Song M; Yang T; Zheng L; Wu D; Shao X; Shi G
Clin Radiol; 2023 Sep; 78(9):e660-e667. PubMed ID: 37344324
[TBL] [Abstract] [Full Text] [Related]
14. An Immunohistochemical Study of Breast cancer brain Metastases: The Role of CD44 and AKT in the prognosis.
Martins Gama J; Caetano Oliveira R; Teixeira P; Silva F; Abrantes C; Figueiredo P; Simões S; Rebelo O; Cipriano MA
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):318-323. PubMed ID: 37093706
[TBL] [Abstract] [Full Text] [Related]
15. Available Systemic Treatments and Emerging Therapies for Breast cancer brain Metastases.
Rader RK; Anders CK; Lin NU; Sammons SL
Curr Treat Options Oncol; 2023 Jun; 24(6):611-627. PubMed ID: 37071254
[TBL] [Abstract] [Full Text] [Related]
16. Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast cancer Patients Who Had Developed brain Metastasis in the Treatment Process.
Dogan I; Kizildag I; Özkurt S; Ibis K; Vatansever S; Saip P; Aydiner A
Oncology; 2023; 101(4):262-269. PubMed ID: 36809751
[TBL] [Abstract] [Full Text] [Related]
17. A Two-Step Feature Selection Radiomic Approach to Predict Molecular Outcomes in Breast cancer.
Brancato V; Brancati N; Esposito G; La Rosa M; Cavaliere C; Allarà C; Romeo V; De Pietro G; Salvatore M; Aiello M; Sangiovanni M
Sensors (Basel); 2023 Jan; 23(3):. PubMed ID: 36772592
[TBL] [Abstract] [Full Text] [Related]
18. Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and prognosis of Triple Negative Breast cancer.
Zins K; Peka E; Miedl H; Ecker S; Abraham D; Schreiber M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768147
[TBL] [Abstract] [Full Text] [Related]
19. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic Factors and Survival According to Tumor Subtype in Women With Breast cancer brain Metastases.
Lopes S; Vieira I; Abreu M; Pousa I; Ferreira A; Sousa S; Pereira D
Curr Probl Cancer; 2022 Dec; 46(6):100866. PubMed ID: 36179388
[TBL] [Abstract] [Full Text] [Related]
[Next]
